Baidu
map

JAMA Surgery:手术减肥后不但体重反弹,而且糖尿病缓解率也降低

2015-08-06 崔倩 译 MedSci原创

    腹腔镜袖状胃切除术可以减肥和改善肥胖相关的疾病,根据在线发表在JAMA杂志的一项研究,长期随访显示随着时间的变化,这种方法会导致体重反弹显著和糖尿病的缓解率的降低,以及在较小程度上,也会出现一些肥胖相关的疾病。        肥胖是15年前被世界卫生组织公认的全球流行病,并且肥胖率一直在增加。肥胖被认为是当前一个严重的健

腹腔镜袖状胃切除术可以减肥和改善肥胖相关的疾病,根据在线发表在JAMA杂志的一项研究,长期随访显示随着时间的变化,这种方法会导致体重反弹显著和糖尿病的缓解率的降低,以及在较小程度上,也会出现一些肥胖相关的疾病。 
   
肥胖是15年前被世界卫生组织公认的全球流行病,并且肥胖率一直在逐年增加。肥胖被认为是当前一个严重的健康危害和糖尿病高血压、异常脂质水平、心脏衰竭、以及其它相关的病症的危险因素。与非手术干预措施相比,减重手术被报道是最有效的减重策略。根据文章的背景信息,腹腔镜袖状胃切除术(LSG)是一种常见的和有效的减肥手术,过去几年中在西方日益普及,但其对肥胖相关疾病的长期效果的数据却很少。
 
以色列佩塔提克瓦贝林松医院的医学博士Andrei Keidar和同事们收集了在2006年4月和2013年2月间在一所大学医院进行LSGs的患者数据,包括人口的细节,体重随访,血液检测结果以及药物治疗和合并症的信息。

研究中共有443例LSGs。在1年的随访过程中54%患者的完整的数据可用,在3年随访时49%的患者的完整的数据可用,在5年随访时70%患者的完整的数据可用。在1,3和5年时过量体重减轻的百分比分别为77%,70%,和56%;糖尿病患者保持完全缓解的患者分别为51%,38%和20%,高血压保持缓解的患者分别为46%,48%和46%。

低密度脂蛋白胆固醇水平的下降仅在1年和3年时显著。总胆固醇水平(术前和在1,3,和5年)的变化没有达到统计学意义。
    
“的后续的随访数据显示,出现了体重恢复和2型糖尿病缓解率降低以及其它与肥胖相关的合并症。这些数据应该在决定是否给一名肥胖患者进行手术时予以考虑,”作者写道。

“这些知识的关键差距构成了一个明细的问题,即人们考虑潜在的手术选择治疗严重肥胖。帮助这些缺陷的比较试验较少,并缺乏随访,缺乏标准化健康状态的变化的定义(如糖尿病缓解),并在手术治疗方案的选择中急于做出判断。”

“临床医生和前瞻性的患者,需要在最新可用数据的驱动而不是由最后结论的驱动下的动态交流中进行讨论和权衡证据。”

原始出处:

Andrei Keidar, MD et al. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy,JAMA Surgery,2015.8.6

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877665, encodeId=9fc218e76655b, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sat Jul 09 11:18:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021501, encodeId=98402021501ce, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 06:18:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525975, encodeId=9d8215259e53f, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sat Aug 08 04:18:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34911, encodeId=b7ed3491153, content=为以后指南更新提供了证据, beContent=null, objectType=article, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78351636049, createdName=shuaijing1986, createdTime=Thu Aug 06 18:24:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2016-07-09 chg121
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877665, encodeId=9fc218e76655b, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sat Jul 09 11:18:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021501, encodeId=98402021501ce, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 06:18:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525975, encodeId=9d8215259e53f, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sat Aug 08 04:18:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34911, encodeId=b7ed3491153, content=为以后指南更新提供了证据, beContent=null, objectType=article, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78351636049, createdName=shuaijing1986, createdTime=Thu Aug 06 18:24:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877665, encodeId=9fc218e76655b, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sat Jul 09 11:18:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021501, encodeId=98402021501ce, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 06:18:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525975, encodeId=9d8215259e53f, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sat Aug 08 04:18:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34911, encodeId=b7ed3491153, content=为以后指南更新提供了证据, beContent=null, objectType=article, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78351636049, createdName=shuaijing1986, createdTime=Thu Aug 06 18:24:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877665, encodeId=9fc218e76655b, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Sat Jul 09 11:18:00 CST 2016, time=2016-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021501, encodeId=98402021501ce, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Sat May 28 06:18:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525975, encodeId=9d8215259e53f, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sat Aug 08 04:18:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=34911, encodeId=b7ed3491153, content=为以后指南更新提供了证据, beContent=null, objectType=article, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78351636049, createdName=shuaijing1986, createdTime=Thu Aug 06 18:24:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-08-06 shuaijing1986

    为以后指南更新提供了证据

    0

相关资讯

Diabetes Care:减重手术或可有效缓解1型糖尿病

美国俄亥俄州克利夫兰医学中心的Brethauer教授等进行的一项研究发现,减重手术可有效缓解1型糖尿病。该研究在线发表在2013年02月20日的Diabetes Care杂志上。 该研究是一项小型研究,10例重度肥胖、血糖控制欠佳的1型糖尿病患者接受了减重手术治疗,术后3年期间,这些患者不仅体重下降,而且血糖控制和代谢指标也有所改善。 这些患者手术时体重指数的均数为41.6kg

Baidu
map
Baidu
map
Baidu
map